01279nam 2200361 450 99657477830331620230415091852.01-7281-7744-8(CKB)5600000000092596(NjHacI)995600000000092596(EXLCZ)99560000000009259620230415d2021 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrier2021 IEEE International Conference on Networking, Architecture and Storage (NAS) /Institute of Electrical and Electronics EngineersPiscataway :IEEE,2021.1 online resource illustrations (some color)1-7281-7745-6 2021 IEEE International Conference on Networking, Architecture and Storage Storage area networks (Computer networks)CongressesComputer architectureCongressesStorage area networks (Computer networks)Computer architecture004.6NjHacINjHaclPROCEEDING9965747783033162021 IEEE International Conference on Networking, Architecture and Storage (NAS)2811952UNISA03107nam 22005895 450 991098778870332120260304163010.0981-9757-42-810.1007/978-981-97-5742-8(CKB)37916648100041(DE-He213)978-981-97-5742-8(MiAaPQ)EBC31959371(Au-PeEL)EBL31959371(OCoLC)1524420232(EXLCZ)993791664810004120250313d2025 u| 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierPreclinical cancer models for translational research and drug development /edited by Suresh P.K., Arindam Banerjee1st ed. 2025.Singapore :Springer Nature Singapore :Imprint: Springer,2025.1 online resource (XI, 168 p. 51 illus., 50 illus. in color.)Medicine Series981-9757-41-X Preclinical Models for Cancer Research and Development.-Insight on the Current Advancements in the Diagnosis and Treatment of Head and Neck Cancer -- The role of oral cancer heterogeneity in therapies in various cellular and preclinical models -- In-depth analysis of Self-assembled in-vitro spheroidal and organoid systems -- Preclinical in vivo animal xenograft models -- Heterogeneity and biomarkers of therapeutic response and resistance -- Higher Order in vitro Models of dysregulated bioenergetics mechanisms and drug development -- In Silico Strategies for Cancer Model Development and Anticancer Drug Testing.This book provides updated information on certain in vitro and preclinical in vivo cancer models. The topics covered include an update on advancements in the diagnosis, treatment and heterogeneity in certain cancers; the development of preclinical in vitro and xenograft-based in vivo cancer models as well as their validation based on widely-accepted biomarkers; modelling of aberrations in bioenergetics in cancers. Also, the importance and latest advances of in silico modeling for the design of new and potent anti-cancer drugs has been reviewed. Cutting-edge and resourceful, this book is valuable for researchers, academicians, and professionals involved in cancer research.CancerCancerAnimal modelsTumor markersCancersCancer ModelsTumour BiomarkersCancer.CancerAnimal models.Tumor markers.Cancers.Cancer Models.Tumour Biomarkers.571.978616.994P.K Sureshedthttp://id.loc.gov/vocabulary/relators/edtBanerjee Arindamedthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910987788703321Preclinical cancer models for translational research and drug development4337474UNINA